AKAP1 enhances glycogen accumulation and hepatocarcinogenesis through YTHDF2-mediated G6PC mRNA decay

Tao Yang, Jiahao Zhang, Zifeng Zhao, Shixia Cheng, Zeyu Yan, Weifang Wang, Gang Wang, Renyu Zhang, Zhang Zhang, Peng Yuan, Xuyang Zheng, Hongxin Zhang, Jibin Li, Jinliang Xing · 2026

Read AKAP1 enhances glycogen accumulation and hepatocarcinogenesis through YTHDF2-mediated G6PC mRNA decay by Tao Yang, Jiahao Zhang, Zifeng Zhao, Shixia Cheng, Zeyu Yan, Weifang Wang, Gang Wang, Renyu Zhang, Zhang Zhang, Peng Yuan, Xuyang Zheng, Hongxin Zhang, Jibin Li, Jinliang Xing (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13272682.txt.

Description

Tao Yang leads a 2026 study linking a protein called AKAP1 to glycogen build-up and liver cancer in mice. Glycogen is a stored form of sugar, and its handling is rewired in many cancers for reasons that are not clear. The team raised or lowered AKAP1 in mouse livers.

Lower AKAP1 cut liver glycogen and slowed both chemical-induced and gene-driven liver cancers, while higher AKAP1 did the reverse. AKAP1 helps a partner protein break down the message for an enzyme that frees sugar, raising glycogen. A peptide that blocks AKAP1 from reaching its site lowered glycogen and curbed cancer in mice, with no clear toxicity seen.

Catalog record

CREATORTao Yang, Jiahao Zhang, Zifeng Zhao, Shixia Cheng, Zeyu Yan, Weifang Wang, Gang Wang, Renyu Zhang, Zhang Zhang, Peng Yuan, Xuyang Zheng, Hongxin Zhang, Jibin Li, Jinliang Xing
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE78095
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13272682

Browse the full library · About the Tower of Babel